Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bullinger

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Leukemia|July 16, 2015
Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERGK Nowek, S M Sun, L Bullinger, et al.
Leukemia|December 18, 2009
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysisL Bullinger, J Krönke, C Schön, et al.
Scientific Reports|September 15, 2019
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic informationT J Ettrich, D Schwerdel, A Dolnik, et al.
Leukemia|October 22, 2015
Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivoP Arreba-Tutusaus, T S Mack, L Bullinger, et al.
Annals of Clinical and Translational Neurology|July 13, 2024
An ordinal clinical score predicts seizure freedom after minimally invasive epilepsy surgeryAdam S Dickey, Katie L Bullinger, Dayton Grogan, et al.
Leukemia|December 14, 2012
Cell of origin determines clinically relevant subtypes of MLL-rearranged AMLA V Krivtsov, M E Figueroa, A U Sinha, et al.
Leukemia|July 20, 2012
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevanceF G Rücker, A C Russ, S Cocciardi, et al.
Leukemia|March 30, 2011
Gene expression profiling in MDS and AML: potential and future avenuesK Theilgaard-Mönch, J Boultwood, S Ferrari, et al.
Epilepsia|June 10, 2023
Stereoelectroencephalography-guided radiofrequency ablation of the epileptogenic zone as a treatment and predictor of future success of further surgical interventionJessica A Shields, Alex C M Greven, Veeresh K N Shivamurthy, et al.
Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Leukemia|July 16, 2015
Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERGK Nowek, S M Sun, L Bullinger, et al.
Leukemia|December 18, 2009
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysisL Bullinger, J Krönke, C Schön, et al.
Scientific Reports|September 15, 2019
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic informationT J Ettrich, D Schwerdel, A Dolnik, et al.
Leukemia|October 22, 2015
Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivoP Arreba-Tutusaus, T S Mack, L Bullinger, et al.
Annals of Clinical and Translational Neurology|July 13, 2024
An ordinal clinical score predicts seizure freedom after minimally invasive epilepsy surgeryAdam S Dickey, Katie L Bullinger, Dayton Grogan, et al.
Leukemia|December 14, 2012
Cell of origin determines clinically relevant subtypes of MLL-rearranged AMLA V Krivtsov, M E Figueroa, A U Sinha, et al.
Leukemia|July 20, 2012
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevanceF G Rücker, A C Russ, S Cocciardi, et al.
Leukemia|March 30, 2011
Gene expression profiling in MDS and AML: potential and future avenuesK Theilgaard-Mönch, J Boultwood, S Ferrari, et al.
Epilepsia|June 10, 2023
Stereoelectroencephalography-guided radiofrequency ablation of the epileptogenic zone as a treatment and predictor of future success of further surgical interventionJessica A Shields, Alex C M Greven, Veeresh K N Shivamurthy, et al.
Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.
Pageof 8